Quarterly report pursuant to Section 13 or 15(d)

Cover

v3.21.2
Cover - shares
 6 Months Ended
Jun. 30, 2021
Aug. 09, 2021
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2021  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2021  
Current Fiscal Year End Date --12-31  
Entity File Number 001-36019  
Entity Registrant Name TONIX PHARMACEUTICALS HOLDING CORP.  
Entity Central Index Key 0001430306  
Entity Tax Identification Number 26-1434750  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 26 Main Street  
Entity Address, Address Line Two Suite 101  
Entity Address, City or Town Chatham  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07928  
City Area Code (212)  
Local Phone Number 980-9155  
Title of 12(b) Security Common Stock  
Trading Symbol TNXP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   357,521,582